Management of Pelvic Pain in Patients with Crohn’s Disease—Current Overview
Authors:
- Jakub WłodarczykJWJakub Włodarczyk
- Jacek BurzyńskiJBJacek Burzyński
- Bartłomiej CzerwińskiBCBartłomiej Czerwiński
- Mateusz PrusiszMPMateusz Prusisz
- Katarzyna SocałaKSKatarzyna Socała
- Ewa PoleszakEwa Poleszak
- Jakub FichnaJFJakub Fichna
- Kasper MaryńczakKMKasper Maryńczak
- Marcin WłodarczykMWMarcin Włodarczyk
- Łukasz DzikiŁDŁukasz Dziki
Open Access
- 9 January 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 526
Abstract
Crohn’s disease (CD) is a subtype of chronic inflammatory bowel diseases (IBD) with characteristic skip lesions and transmural inflammation that may affect the entire gastrointestinal tract from the mouth to the anus. Persistent pain is one of the main symptoms of CD. This pain has multifactorial pathogenesis, but most often arises from intestinal inflammation itself, as well as from gut distention or partial intestinal obstruction. Some current evidence also suggests sensitization of sensory pathways, as well as modulation of those signals by the central nervous system, which highlights the impact of biopsychosocial factors. To date, most studies have focused only on the pain located in the abdomen, while pelvic pain has rarely been explored, despite it being a common symptom. The aim of this study is to provide an abbreviated summary of the current state of knowledge on the origins and treatment of pelvic pain in CD.Keywords
Funding Information
- Medical University of Lodz, Poland
This publication has 71 references indexed in Scilit:
- Transient Receptor Potential Vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?Neurogastroenterology & Motility, 2012
- Pain management in patients with inflammatory bowel disease: insights for the clinicianTherapeutic Advances in Gastroenterology, 2012
- Gynecologic management of neuropathic painAmerican Journal of Obstetrics and Gynecology, 2011
- Centrally Acting Therapies for Irritable Bowel SyndromeGastroenterology Clinics of North America, 2011
- The multiple functions of the endocannabinoid system: a focus on the regulation of food intakeDiabetology & Metabolic Syndrome, 2010
- Pain and inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Opioid-induced immunosuppressionCurrent Opinion in Supportive & Palliative Care, 2008
- The Narcotic Bowel Syndrome: Clinical Features, Pathophysiology, and ManagementClinical Gastroenterology and Hepatology, 2007
- Effect of a second-generation α 2 δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndromeGut, 2007
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006